Sign In
Buy EKSO
$11.80
+0 (+0%)
At Close: Jun 03, 2026
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
08:00am, Wednesday, 06'th May 2026
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced t
Insider Buying: Ekso Bionics (NASDAQ:EKSO) Major Shareholder Purchases $191,142.00 in Stock
05:52am, Monday, 23'rd Feb 2026
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO - Get Free Report) major shareholder Daniel Asher bought 15,540 shares of the company's stock in a transaction dated Thursday, February 19th. The shares were
Ekso Bionics Prices $5.852 million Private Placement
08:30am, Wednesday, 21'st Jan 2026
SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announce
Why Applied Digital Stock Is Jumping Today
08:21am, Thursday, 08'th Jan 2026
Applied Digital (APLD) shares surged about 10% on Thursday morning after the company reported fiscal second-quarter revenue of $126.6 million for the period end
Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights
02:27pm, Wednesday, 07'th Jan 2026
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)
02:22pm, Monday, 05'th Jan 2026
NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is re
Consumer tech news roundup covering AI investments, semiconductor tensions, EV delivery updates, Big Tech strategy shifts, and policy developments shaping global technology markets.
Applied Digital and EKSO Bionics Plan Strategic Business Combination
11:14am, Tuesday, 30'th Dec 2025
Applied Digital (APLD) is maintaining a steady trading position after announcing a non-binding term sheet with EKSO Bionics (EKSO). This proposed business combi
Halper Sadeh LLC Encourages EKSO, FOLD, WBD, CFLT Shareholders to Contact the Firm to Discuss Their Rights
10:19am, Tuesday, 30'th Dec 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Applied Digital And The EKSO Transaction: Buy This Clear Story
09:10am, Tuesday, 30'th Dec 2025
Applied Digital Corporation is moving from a mixed and hard-to-value structure into two focused businesses with clearer roles, funding paths and investor bases. The cloud separation creates a pure AI
EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders
05:54am, Tuesday, 30'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO) and Applied Digital Cloud is fair to EKSO sh
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
04:45pm, Monday, 29'th Dec 2025
DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artific
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System
07:45am, Thursday, 04'th Dec 2025
SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technol
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
01:01pm, Friday, 21'st Nov 2025
Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
08:00am, Wednesday, 29'th Oct 2025
SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announce
